 |
 |
 |
 |
 |
 |
Grauer SM, Graf R, Navarra R, Sung A, Logue SF, Stack G, Huselton C, Liu Z, Comery TA, Marquis KL, Rosenzweig-Lipson S.
WAY-163909, a 5-HT2C agonist, enhances the preclinical potency of current antipsychotics. Psychopharmacology (Berl).
2009 May 1
;
204(1):37-48.
Pubmed Abstract
|
 |
|